Ask AI
ProCE Banner Activity

Worry Free in HAE: Coffee Talks With the Experts on Leveraging Advances in Long-term Prophylaxis

Video

On-demand webcast of expert faculty presentation on the latest advances in managing hereditary angioedema (HAE), including the latest data on new and emerging long-term prophylactic therapies for patients with HAE.

Released: December 02, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals.

Ionis Pharmaceuticals

Target Audience

This program is intended for allergy/immunology healthcare professionals and others who care for patients with HAE, including physicians, residents, fellows, nurse practitioners, and physician associates.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Hereditary Angioedema.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize unmet needs of patients living with HAE

  • Collaborate with patients to identify barriers and promote improved adherence and acceptance of long-term prophylaxis in HAE

  • Assess new and emerging long-term prophylactic therapies according to clinical profile and recent safety and efficacy data

  • Identify patients who would benefit from optimization of long-term prophylaxis

Faculty Disclosure

Primary Author

Aleena Banerji, MD: consultant/advisor/speaker: ADARx, Astria, BioCryst, CSL, Intellia, Ionis, Kalvista, Pharvaris; researcher: Astria, Intellia, Ionis.

William R. Lumry, MD: consultant: Astria, BioCryst, BioMarin, CSL Behring, Express Scripts/CVS, Intellia, Kalvista, Magellan, Optum, Pharming, Pharvaris, Shire/Takeda; speaker: AstraZeneca, BioCryst, CSL Behring, Grifols, Kalvista, Pharming, Regeneron, Shire/Takeda; researcher: AstraZeneca, Astria, BioMarin, CSL Behring, Grifols, Intellia, Ionis, Kalvista, Lilly, Novartis, Pharvaris, Shire/Takeda, Teva, Up Stream Bio.

Marc Riedl, MD, MS: researcher: Astria, Biocryst, BioMarin, CSL Behring, Intellia, Ionis, Kalvista, Pharvaris, Takeda; consultant/advisor/speaker: Astria, BioCryst, BioMarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, Ionis, Kalvista, Novartis, Pharming, Pharvaris, Sanofi/Regeneron, Takeda.

Format

This program has been made available online.